BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/24/2026 9:13:56 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-12-30 09:11 |
 |
Peer-Review Started |
|
2025-12-30 09:11 |
 |
First Decision by Editorial Office Director |
|
2026-01-19 07:25 |
 |
Return for Revision |
|
2026-01-19 07:25 |
 |
Revised |
|
2026-01-29 06:50 |
 |
Publication Fee Transferred |
|
2026-02-07 10:02 |
 |
Second Decision by Editor |
|
2026-03-18 02:37 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-03-18 07:16 |
 |
Articles in Press |
|
2026-03-18 07:16 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2026-06-09 00:24 |
 |
Publish the Manuscript Online |
|
2026-06-24 09:13 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© Author(s) (or their employer(s)) 2026. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Randomized Controlled Trial |
| Article Title |
Application of mirabilite in gastrointestinal surgery: A randomized controlled trial
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Tai-Yuan Li, Rui-Xiang Zou, Fang-Zheng Min, A-Long Luo and Shan-Ping Ye |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Jiangxi Province Traditional Chinese Medicine Science and Technology Plan Project |
2023B0925 |
|
| Corresponding Author |
Shan-Ping Ye, Chief Physician, MD, PhD, Department of General Surgery, The First Affiliated Hospital of Nanchang University, No. 17 Yongwaizheng Street, Nanchang 330000, Jiangxi Province, China. ndyfy08807@ncu.edu.cn |
| Key Words |
Mirabilite; Gastrointestinal surgery; Surgical site infection; Postoperative gastrointestinal dysfunction; C-reactive protein |
| Core Tip |
This randomized controlled trial provides robust evidence that the topical application of mirabilite, a traditional external therapy, is a simple yet effective adjunct to standard postoperative care in gastrointestinal surgery. The treatment demonstrates multifaceted benefits: It significantly accelerates recovery of gastrointestinal function, reduces postoperative pain and systemic inflammation, decreases drainage volume, and lowers the incidence of surgical site infections. These clinically meaningful outcomes led to a shorter hospital stay, highlighting mirabilite’s potential to improve patient recovery and optimize healthcare efficiency. Mirabilite application represents a safe, practical, and valuable non-invasive strategy to enhance short-term surgical recovery. |
| Publish Date |
2026-06-24 09:13 |
| Citation |
Li TY, Zou RX, Min FZ, Luo AL, Ye SP. Application of mirabilite in gastrointestinal surgery: A randomized controlled trial. World J Gastrointest Surg 2026; 18(6): 118317
|
| URL |
https://www.wjgnet.com/1948-9366/full/v18/i6/118317.htm |
| DOI |
https://doi.org/10.4240/wjgs.118317 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.